Isomorphic Labs

Isomorphic Labs, a pioneering company in AI-driven drug discovery, successfully raised £1.6 billion ($2.1 billion) in a significant funding round during the first half of 2026, contributing to a record period for UK startup investment.

Summary of transaction details:

• Value: £1.6 Billion ($2.1 Billion)
• Sector: Healthcare & Biotech
• Advisor: Not disclosed
• Key Entities: Target: Isomorphic Labs; Investor: Not disclosed
• Location: United Kingdom (as part of UK funding trends)

Note: This transaction exemplifies the strong investor appetite for deep tech and AI innovations, particularly within the life sciences sector, reinforcing the UK's growing prominence in the global venture capital landscape.